Pharma News

Bioavailibity

Bioavailibity: Oils, capsules, vapes, gummies and balms

Here, we have a brief look at the different methods of using CBD, and how each method affects bioavailability.
UK’s cannabis laws

What next for the UK’s cannabis laws?

John Binns, Partner at BCL Solicitors LLP looks at the UK’s cannabis laws and how they could be improved.
medical cannabis & CBD

IP protection in fast-moving global markets: Medical cannabis & CBD

Laura Clews, Managing Associate at IP attorneys Mathys & Squire, analyses the protection for innovative new products in the medical cannabis & CBD sector.
cannabinoid extraction

From Cannabis flower to final products: Extractions for Phytopharmaceuticals

Dr Nikos Xynos, PhD in Pharmaceutical Sciences/Natural Products Chemistry and MD a Nomad Labs, explores the various pathways to cannabinoid extraction, refining and purification technologies.
medicinal cannabis

Medicinal cannabis: What the UK can learn from Denmark

Spectrum Therapeutics UK lifts the lid here on a pilot analysis of medicinal cannabis use that will run in Denmark until January 2022.
Psoriasis and Rheumatoid Arthritis, cannabinoids

Cannabinoids in Medicine Part 3: Psoriasis and Rheumatoid Arthritis

Following the first two articles that discussed the treatment of cancer and pain, this third piece will focus on the use of cannabinoids to treat psoriasis and rheumatoid arthritis.
UK’s medical cannabis industry

The UK’s medical cannabis industry

Dr. Frank D'Ambrosio, CMO of Block Commodities Plc, provides an insight into the UK’s medical cannabis industry.
cannabinoid CBDa

The importance of cannabinoid CBDa (cannabidiolic acid)

Katharina Zedlacher, PR and communications at BioBloom GmbH, details the recent studies conducted to highlight how cannabinoid CBDa (cannabidiolic acid) increases bioavailability of CBD and its health-promoting properties.
cannabinoid research

Closing gaps in cannabinoid research to make progress in pain management

David Shurtleff, PhD, Deputy Director at the National Center for Complementary and Integrative Health, National Institutes of Health (NIH), shares his thoughts on closing gaps in cannabinoid research to make progress in pain management.
purchasing cannabidiol

Purchasing cannabidiol: Have you been mis-sold CBD?

Gregory Land, CEO at Canna CBD Limited, highlights the dangers of purchasing cannabidiol (CBD) from an unreputable source.

CBD in food and beverages

John Wallace, Managing Director at Mile High Labs International, Ltd. explores the market of CBD in food and beverages, including regulation.
future of agricultural hemp

A vision for the future of agricultural hemp

Paul McCourt, CEO and Founder of Celtic Wind Crops, outlines his vision for the future when it comes to how growing hemp in the local community can help a global crisis.
drug policy reform, psychedelic

The Psychedelic Renaissance and the importance of drug policy reform

In the view of Amanda Feilding, Founder of the Beckley Foundation, “Psychedelics are unique pharmacological compounds that hold the promise of a profound paradigm shift in psychiatry.” Here, we learn about the Psychedelic Renaissance and the importance of drug policy reform.
cultivation of medical cannabis

How important is light for the cultivation of medical cannabis?

Here, Christoph Schubert discusses how light is one of the most important factors in the professional cultivation of medical cannabis.
cannabis industry

The value of accreditation in the cannabis industry

Chris Gunning, General Manager – Accreditation Services at A2LA, discusses the value of accreditation in today’s cannabis industry.

Winchester MD: Ahead of the curve in the market for CBD products

Farrukh Saleem, Head of Sales & Marketing at Winchester MD, explains why the company is ahead of the curve when it comes to today’s market for CBD products.
CBD cultivation

Jersey Hemp granted CBD cultivation licence

Jersey Hemp share that they have been granted the first licence in the British Isles to harvest hemp flowers for CBD, in this article.
treat type 2 diabetes

Can cannabidiol (CBD) treat Type 2 diabetes?

Here, OilsBySimpson Founder Kevin Simpson and Clinical Professor, Consultant Physician and Research Director, Filip Krag Knop, explain what we know so far about CBD’s effect on Type 2 diabetes and why running a clinical trial is so important.
treat multiple sclerosis

Can CBD be used to treat multiple sclerosis (MS)?

Content Marketing Specialist, Tammy Taylor details how CBD can be used to treat multiple sclerosis (MS) in this article.
questions about CBD

The most common questions about CBD – Answered

Here, Keeley Berry, Nutritional Expert and Product Developer at BetterYou, answers the most commonly asked questions about CBD.

Follow Open Access Government

Related Special Reports

Related eBooks